Transfer pricing, ESOP and weighted deduction rulings shape relief on comfort letters, clinical trials and business expenditure.

The Tribunal considered multiple tax issues, holding that a letter of comfort for an associated enterprise's borrowing did not amount to a corporate guarantee and no transfer pricing adjustment survived. It upheld deduction of ESOP expenditure as employee cost, allowed weighted deduction for eligible clinical trial expenditure and clarified that Form 3CL was not ative for denying relief in the relevant period, and allowed pre-commencement revenue expenditure linked to an existing business extension. It also sustained disallowance of sales promotion expenses. Matters concerning depreciation on unverified purchases and goodwill, section 10AA computation, and mark-to-market loss on certain derivative contracts were remitted for fresh examination or factual verification.

---

---

Issues: (i) Whether consequential depreciation on unverified purchases and other expenses, and depreciation on goodwill arising on amalgamation, required fresh examination by the Assessing Officer; (ii) Whether a letter of comfort issued to support borrowing of an associated enterprise constituted a guarantee warranting transfer pricing adjustment; (iii) Whether deduction under section 10AA was to be computed on commercial profits and not after adjustments made under the Act; (iv) Whether mark-to-market loss on outstanding derivative contracts was allowable; (v) Whether disallowance of sales promotion expenses was sustainable; (vi) Whether ESOP expenditure was allowable as deduction; (vii) Whether weighted deduction under section 35(2AB) was allowable for clinical trial expenditure incurred outside the approved in-house facility and for expenditure not certified in Form 3CL; and (viii) Whether pre-commencement revenue expenditure was allowable.

Issue (i): Whether consequential depreciation on unverified purchases and other expenses, and depreciation on goodwill arising on amalgamation, required fresh examination by the Assessing Officer.

Analysis: The disallowance on unverified purchases and expenses was held to be consequential to the treatment given in earlier years, and the Tribunal followed its own earlier view directing fresh examination of the underlying factual position. On goodwill, the Tribunal noted that the claim arose from amalgamation and that the factual and legal aspects, including the nature of the goodwill and its eligibility under the depreciation provision, had not been fully examined by the tax authorities. Both matters were therefore sent back for reconsideration.

Conclusion: The issue was not finally decided on merits and was remitted to the Assessing Officer.

Issue (ii): Whether a letter of comfort issued to support borrowing of an associated enterprise constituted a guarantee warranting transfer pricing adjustment.

Analysis: The Tribunal examined the terms of the document and the related lending conditions and found that the instrument did not create an enforceable indemnity or financial obligation on the assessee comparable to a corporate guarantee. It distinguished a letter of comfort from a guarantee and also noted that the relevant safe harbour definition of corporate guarantee did not include a mere letter of comfort.

Conclusion: The transfer pricing adjustment was deleted and the issue was decided in favour of the assessee.

Issue (iii): Whether deduction under section 10AA was to be computed on commercial profits and not after adjustments made under the Act.

Analysis: The Tribunal admitted the additional ground as a pure question of law, but the point had not been examined by the lower authorities on the necessary factual matrix. Following its earlier approach in similar circumstances, it held that the claim required verification at the assessment stage in the light of the applicable precedent.

Conclusion: The issue was remitted to the Assessing Officer for fresh examination.

Issue (iv): Whether mark-to-market loss on outstanding derivative contracts was allowable.

Analysis: The Tribunal followed the jurisdictional precedent on hedging and foreign exchange related losses but noticed that part of the claim related to ineffective option contracts and derivative write-off, the exact nature of which had not been examined by the tax authorities. For that limited factual verification, the matter was restored to the Assessing Officer.

Conclusion: The issue was restored to the Assessing Officer.

Issue (v): Whether disallowance of sales promotion expenses was sustainable.

Analysis: The Tribunal found the issue to be covered against the assessee and accepted the Revenue's challenge.

Conclusion: The disallowance was confirmed and the issue was decided in favour of the Revenue.

Issue (vi): Whether ESOP expenditure was allowable as deduction.

Analysis: The Tribunal followed its earlier decision and the Special Bench ruling that ESOP discount represents employee cost and is deductible as expenditure. It also reiterated that the absence of a corresponding book entry does not control the computation of total income where the claim is otherwise allowable under the Act.

Conclusion: The deduction was allowed and the issue was decided in favour of the assessee.

Issue (vii): Whether weighted deduction under section 35(2AB) was allowable for clinical trial expenditure incurred outside the approved in-house facility and for expenditure not certified in Form 3CL.

Analysis: For clinical trial expenditure, the Tribunal relied on the statutory explanation and binding precedent to hold that such expenditure in the pharmaceutical business can qualify even if incurred outside the in-house facility. On the Form 3CL issue, it held that prior to the relevant amendment the form did not have conclusive legal sanctity for denying deduction where the facility stood approved and the expenditure was otherwise eligible.

Conclusion: The weighted deduction was upheld and the issue was decided in favour of the assessee.

Issue (viii): Whether pre-commencement revenue expenditure was allowable.

Analysis: The Tribunal followed its earlier view that the unit had been set up and that the expenditure related to an extension of the existing business, making the revenue expenditure deductible.

Conclusion: The expenditure was allowed and the issue was decided in favour of the assessee.

Final Conclusion: The assessee obtained relief on the core transfer pricing, ESOP, weighted deduction and pre-commencement expenditure issues, while some issues were remitted for fresh examination and the sales promotion disallowance was sustained.

---